HIV-1 drug resistance evolution during persistent near target viral suppression

被引：0
|
作者：
Taiwo, B. [1 ]
Gallien, S. [2 ]
Aga, E. [3 ]
Ribaudo, H. [3 ]
Haubrich, R. [4 ]
Kuritzkes, D. [2 ]
Eron, J. [5 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Univ N Carolina, Chapel Hill, NC USA
来源：
ANTIVIRAL THERAPY | 2010年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [41] Insertions and deletions in HIV-1 reverse transcriptase:: Consequences for drug resistance and viral fitness
    Menendez-Arias, Luis
    Matamoros, Tania
    Cases-Gonzalez, Clara E.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (15) : 1811 - 1825
  • [42] DYNAMICS BEHAVIOR OF MUTATION DURING REPRODUCTION ON HIV-1 DRUG RESISTANCE
    Huang, Guangyu
    Fan, Aijun
    Wang, Kaifa
    INTERNATIONAL JOURNAL OF BIOMATHEMATICS, 2013, 6 (03)
  • [43] The effect of transmitted HIV-1 drug resistance on pre-therapy viral load
    Harrison, L.
    Castro , H.
    Cane, P.
    Pillay, D.
    Booth, C.
    Phillips, A.
    Geretti, A. M.
    Dunn, D.
    ANTIVIRAL THERAPY, 2010, 15 : A49 - A49
  • [44] Viral evolution in HIV-1 reverse transcriptase in patients receiving a holding regimen with Trizivir® and tenofovir with persistent viral replication
    Llibre, J. M.
    Bonjoch, A.
    Iribarren, J. A.
    Galindo, M. J.
    Martinez-Picado, X.
    Arazo, P.
    Santos, J. R.
    Domingo, P.
    Clotet, B.
    ANTIVIRAL THERAPY, 2007, 12 : S80 - S80
  • [45] Modelling the spread and evolution of HIV-1 drug resistance in concentrated MSM epidemics
    Fraser, C.
    ANTIVIRAL THERAPY, 2014, 19 : A4 - A4
  • [46] Commentary on “Prevalence and evolution of drug resistance HIV-1 variants in Henan, China”
    Bruce L GILLIAM
    Robert R REDFIELD
    Richard Y ZHAO
    Robert C GALLO
    Cell Research, 2005, 15 : 850 - 851
  • [47] Algorithm evolution for drug resistance prediction: comparison of systems for HIV-1 genotyping
    Wagner, Sarah
    Kurz, Mario
    Klimkait, Thomas
    ANTIVIRAL THERAPY, 2015, 20 (06) : 661 - 665
  • [48] Commentary on "Prevalence and evolution of drug resistance HIV-1 variants in Henan, China"
    Gilliam, BL
    Redfield, RR
    Zhao, RY
    Gallo, RC
    CELL RESEARCH, 2005, 15 (11-12) : 850 - 851
  • [49] Community HIV-1 drug resistance is associated with transmitted drug resistance
    Tilghman, M. W.
    Perez-Santiago, J.
    Osorio, G.
    Little, S. J.
    Richman, D. D.
    Mathews, W. C.
    Haubrich, R. H.
    Smith, D. M.
    HIV MEDICINE, 2014, 15 (06) : 339 - 346
  • [50] Difficulty in reaching viral suppression in a long-term treated HIV-1 patient: Role of the reservoir rather than drug resistance?
    Alidjinou, E. K.
    Robineau, O.
    Huleux, T.
    Meybeck, A.
    Hober, D.
    Ajana, F.
    Bocket, L.
    INFECTIOUS DISEASES NOW, 2022, 52 (05): : 315 - 317
12345